课题基金 / 基金详情

THERAPEUTIC EFFECTS AND ABUSE OF GABA(A) MODULATORS

THERAPEUTIC EFFECTS AND ABUSE OF GABA(A) MODULATORS
GABA(A) 调节剂的治疗效果和滥用
批准号:
8357917
负责人:
JAMES K ROWLETT
金额:
$1.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-05-01 至 2012-04-30

项目摘要

项目成果

JAMES K ROWLETT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Benzodiazepines (BZs) are prescribed widely as anxiolytics, hypnotics, muscle relaxants, and anticonvulsants. Although BZs are considered to be among the safest prescription drugs in modern medicine, their utility is constrained by a number of side effects, including unwanted sedation, impaired motor performance, and the liability for addiction. This project seeks to identify the GABA(A) receptor subtype mechanisms underlying the clinically beneficial vs. unwanted side effects of BZ-type drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tolerance and Physical Dependence after Chronic Benzodiazepine Treatment
  • 批准号:
    10162574
  • 项目类别:
  • 资助金额:
    $40.27万
  • 财政年份:
    2017
  • 负责人:
    JAMES K ROWLETT
  • 依托单位:
Neurosteroid-BZ combinations: Strategy for reducing abuse and sedation
Neurosteroid-BZ combinations: Strategy for reducing abuse and sedation
  • 批准号:
    8322247
  • 项目类别:
  • 资助金额:
    $60.22万
  • 财政年份:
    2012
  • 负责人:
    JAMES K ROWLETT
  • 依托单位:
Neurosteroid-BZ combinations: Strategy for reducing abuse and sedation
海外基金